CRISPR segment to dominate the South America Genome Editing Market during 2021–2028

According to a new market research study on “South America Genome Editing Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Technology, Application, and End User” is expected to reach US$ 1,003.03 million by 2028 from US$ 319.10 million in 2021. The market is estimated to grow at a CAGR of 17.8% from 2021 to 2028. The report provides trends prevailing in the South America genome editing market along with the drivers and restraints pertaining to the market growth. Advancing technological innovations, increasing prevalence of cancer and other genetic disorders, and   flourishing developing biotechnology industry in emerging regions are the major factor driving the growth of the South America genome editing market. However, high price of genomic equipment hinders the growth of South America genome editing market.

The outbreak of COVID–19 has stringently affected medical services in the South America region. Also, the nations are famous for medical tourism, which is also influenced by the pandemic. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is affected by the second wave of corona infection. Brazil, Argentina, Uruguay, Chile, Peru, Colombia is concerned by the emerging new variants of the COVID19 virus. Amongst which Brazil has registered the majority of the deaths. It is anticipated that the region will likely force a restriction of the international travelers, which will ultimately affect the healthcare industry in the area.

The South America genome editing market is segmented on the basis of technology, application, end user and country. Based on technology, the market is segmented into CRISPR, TALEN, antisense, and other. In 2021, CRISPR segment held the largest share in the market, it is expected to be the fastest growing segment during the forecast period. Based on application, the market is segmented into cell line engineering, genetic engineering, diagnostic applications, drug discovery, and others. In 2021, genetic engineering segment held the largest share in the market, and cell line engineering is expected to be the fastest growing segment during the forecast period. Based on end user, the market is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations (CRO's). In 2021, pharmaceutical and biotechnology companies segment held the largest share in the market, and it is also expected to be the fastest growing segment during the forecast period. Similarly, based on country the market is segmented into Brazil, Argentina, and Rest of SAM. In 2021, Brazil held the largest share in the market, and it is also expected to be the fastest growing country during the forecast period.

THERMO FISHER SCIENTIFIC INC.; MERCK KGaA; Lonza; Horizon Discovery Group plc.; GenScript; New England Biolabs; Eurofins Scientific; CRISPR Therapeutics; and Editas Medicine are among the leading companies in the South America genome editing market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, Integrated DNA Technologies (IDT), a leading comprehensive genomics solutions provider, has launched its rhAmpSeq CRISPR Analysis System, which offers an end-to-end solution for characterizing and quantifying the full array of on- and off-target genome editing events in CRISPR research projects.

South America Genome Editing Market, By Country, 2021 and 2028 (%)

Contact Us
Phone: +16467917070
Email Id: sales@businessmarketinsights.com